Chimeric antigen receptors combining 4-1BB and CD28 signaling domains augment PI3kinase/AKT/Bcl-XL activation and CD8+ T cell-mediated tumor eradication.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples